How many insider trades does FilingIQ track for TXMD?

FilingIQ tracks 260 Form 4 insider transactions for TXMD (TherapeuticsMD, Inc.), covering filings from May 12, 2015 onwards. 0 of those are dated within the last 90 days.

Are TXMD insiders net buyers or net sellers?

Across the full Form 4 history for TXMD, 59 transactions (23%) were open-market purchases and 76 (29%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does TXMD insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is TXMD in?

TherapeuticsMD, Inc. (TXMD) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $25.00M.

TXMD insider trading

NasdaqGS Healthcare

TherapeuticsMD, Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades

260

Last 90 days

Buys / sells

23% / 29%

Market cap

$25.00M

About TherapeuticsMD, Inc.

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Company website: www.therapeuticsmd.com

TXMD insider activity at a glance

FilingIQ tracks 260 insider transactions for TXMD in filings since May 12, 2015. The most recent transaction is dated Dec 23, 2025.

Across the full history, 59 open-market purchases and 76 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on TXMD insider trades is 53.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live TXMD trades on FilingIQ Raw filings on SEC EDGAR

Latest TXMD Form 4 filings

Walker Marlan D Chief Executive Officer

A Nov 5, 2025

Thompson Tommy G

P Apr 15, 2025

Walker Marlan D Chief Executive Officer

P Apr 15, 2025

Walker Marlan D Chief Executive Officer

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

Frequently asked

How many insider trades does FilingIQ track for TXMD?: FilingIQ tracks 260 Form 4 insider transactions for TXMD (TherapeuticsMD, Inc.), covering filings from May 12, 2015 onwards. 0 of those are dated within the last 90 days.
Are TXMD insiders net buyers or net sellers?: Across the full Form 4 history for TXMD, 59 transactions (23%) were open-market purchases and 76 (29%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TXMD insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is TXMD in?: TherapeuticsMD, Inc. (TXMD) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $25.00M.

Methodology & sources

Every TXMD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.